Low‐dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter

MLA

Xia Shao, et al. “Low‐dose Decitabine Promotes M2 Macrophage Polarization in Patients with Primary Immune Thrombocytopenia via Enhancing KLF4 Binding to PPARγ Promoter.” Clinical and Translational Medicine, vol. 13, no. 7, July 2023. EBSCOhost, https://doi.org/10.1002/ctm2.1344.

APA

Xia Shao, Pengcheng Xu, Lili Ji, Boting Wu, Yanxia Zhan, Xibing Zhuang, Yang Ou, Fanli Hua, Lihua Sun, Feng Li, Xiangdong Wang, Hao Chen, & Yunfeng Cheng. (2023). Low‐dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter. Clinical and Translational Medicine, 13(7). https://doi.org/10.1002/ctm2.1344

Chicago

Xia Shao, Pengcheng Xu, Lili Ji, Boting Wu, Yanxia Zhan, Xibing Zhuang, Yang Ou, et al. 2023. “Low‐dose Decitabine Promotes M2 Macrophage Polarization in Patients with Primary Immune Thrombocytopenia via Enhancing KLF4 Binding to PPARγ Promoter.” Clinical and Translational Medicine 13 (7). doi:10.1002/ctm2.1344.